Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins.

Steegenga WT, Shvarts A, Riteco N, Bos JL, Jochemsen AG.

Mol Cell Biol. 1999 May;19(5):3885-94.

2.

Regulation of the p53 homolog p73 by adenoviral oncogene E1A.

Das S, El-Deiry WS, Somasundaram K.

J Biol Chem. 2003 May 16;278(20):18313-20. Epub 2003 Mar 13.

4.

Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.

Roth J, König C, Wienzek S, Weigel S, Ristea S, Dobbelstein M.

J Virol. 1998 Nov;72(11):8510-6.

5.

Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73.

Higashino F, Pipas JM, Shenk T.

Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15683-7.

6.

The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function.

Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T.

Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1206-11.

7.

The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells.

Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ, Bos JL.

Oncogene. 1998 Jan 22;16(3):349-57.

9.

Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex.

Querido E, Morrison MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE.

J Virol. 2001 Jan;75(2):699-709. Erratum in: J Virol 2001 Mar;75(5):2508. Morisson MR [corrected to Morrison MR].

10.

Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells.

Ishida S, Yamashita T, Nakaya U, Tokino T.

Jpn J Cancer Res. 2000 Feb;91(2):174-80. Erratum in: Jpn J Cancer Res 2000 Jul;91(7):767.

PMID:
10761704
11.

The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.

Spitkovsky D, Steiner P, Gopalkrishnan RV, Eilers M, Jansen-Dürr P.

Oncogene. 1995 Jun 15;10(12):2421-5.

PMID:
7784093
12.

Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.

Savelyeva I, Dobbelstein M.

Oncogene. 2011 Feb 17;30(7):865-75. doi: 10.1038/onc.2010.461. Epub 2010 Oct 11.

PMID:
20935676
13.

Promoter specificity and stability control of the p53-related protein p73.

Lee CW, La Thangue NB.

Oncogene. 1999 Jul 22;18(29):4171-81.

14.

E1A activates transcription of p73 and Noxa to induce apoptosis.

Flinterman M, Guelen L, Ezzati-Nik S, Killick R, Melino G, Tominaga K, Mymryk JS, Gäken J, Tavassoli M.

J Biol Chem. 2005 Feb 18;280(7):5945-59. Epub 2004 Nov 29.

15.
16.

Differential modulation of cellular and viral promoters by p73 and p53.

Deb D, Lanyi A, Scian M, Keiger J, Brown DR, Le Roith D, Deb SP, Deb S.

Int J Oncol. 2001 Feb;18(2):401-9.

PMID:
11172610
18.

The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.

Grand RJ, Lecane PS, Owen D, Grant ML, Roberts S, Levine AJ, Gallimore PH.

Virology. 1995 Jul 10;210(2):323-34.

19.
20.

Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein.

Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T.

J Virol. 2000 Jun;74(11):5168-81.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk